Wednesday, March 4, 2020

Strides Pharma receives USFDA approval for Tetracycline Hydrochloride Capsules

Strides Pharma receives USFDA approval for Tetracycline Hydrochloride Capsules The product is a generic version of Achromycin V Capsules, 250 mg and 500 mg, of Avet Pharmaceuticals Inc. (previously Heritage Pharmaceuticals Inc), the Bengaluru- headquartered company said in a statement.

from Moneycontrol Business News https://ift.tt/2wqCypG
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

KPI Green Energy Q4 cons PAT jumps 46% YoY to Rs 155 cr; revenue up 40%

KPI Green Energy Q4 Results: KPI Green Energy announced strong financial results for the fourth quarter of FY26. Net profit surged by 46% t...